Arikawa-Hirasawa E - Search Results

1

[Roles of perlecan in development and disease: studies in knockout mice and human disorders].

Arikawa-Hirasawa E, Yamada Y. Arikawa-Hirasawa E, et al. Seikagaku. 2001 Oct;73(10):1257-61. Seikagaku. 2001. PMID: 11725543 Review. Japanese. No abstract available.

2

Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice.

Arikawa-Hirasawa E, Rossi SG, Rotundo RL, Yamada Y. Arikawa-Hirasawa E, et al. Nat Neurosci. 2002 Feb;5(2):119-23. doi: 10.1038/nn801. Nat Neurosci. 2002. PMID: 11802174

3

Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia.

Arikawa-Hirasawa E, Le AH, Nishino I, Nonaka I, Ho NC, Francomano CA, Govindraj P, Hassell JR, Devaney JM, Spranger J, Stevenson RE, Iannaccone S, Dalakas MC, Yamada Y. Arikawa-Hirasawa E, et al. Am J Hum Genet. 2002 May;70(5):1368-75. doi: 10.1086/340390. Epub 2002 Apr 8. Am J Hum Genet. 2002. PMID: 11941538 Free PMC article.

4

Perlecan is essential for cartilage and cephalic development.

Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y. Arikawa-Hirasawa E, et al. Nat Genet. 1999 Nov;23(3):354-8. doi: 10.1038/15537. Nat Genet. 1999. PMID: 10545953

5

Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.

Arikawa-Hirasawa E, Wilcox WR, Le AH, Silverman N, Govindraj P, Hassell JR, Yamada Y. Arikawa-Hirasawa E, et al. Nat Genet. 2001 Apr;27(4):431-4. doi: 10.1038/86941. Nat Genet. 2001. PMID: 11279527

6

Dyssegmental dysplasia, Silverman-Handmaker type: unexpected role of perlecan in cartilage development.

Arikawa-Hirasawa E, Wilcox WR, Yamada Y. Arikawa-Hirasawa E, et al. Am J Med Genet. 2001 Winter;106(4):254-7. doi: 10.1002/ajmg.10229. Am J Med Genet. 2001. PMID: 11891676 Review.

7

Role of perlecan in skeletal development and diseases.

Hassell J, Yamada Y, Arikawa-Hirasawa E. Hassell J, et al. Glycoconj J. 2002 May-Jun;19(4-5):263-7. doi: 10.1023/A:1025340215261. Glycoconj J. 2002. PMID: 12975604 Review.

8

Atherosclerosis in perlecan heterozygous mice.

Vikramadithyan RK, Kako Y, Chen G, Hu Y, Arikawa-Hirasawa E, Yamada Y, Goldberg IJ. Vikramadithyan RK, et al. J Lipid Res. 2004 Oct;45(10):1806-12. doi: 10.1194/jlr.M400019-JLR200. Epub 2004 Jul 16. J Lipid Res. 2004. PMID: 15258195 Free article.

9

Targeting perlecan in human keratinocytes reveals novel roles for perlecan in epidermal formation.

Sher I, Zisman-Rozen S, Eliahu L, Whitelock JM, Maas-Szabowski N, Yamada Y, Breitkreutz D, Fusenig NE, Arikawa-Hirasawa E, Iozzo RV, Bergman R, Ron D. Sher I, et al. J Biol Chem. 2006 Feb 24;281(8):5178-87. doi: 10.1074/jbc.M509500200. Epub 2005 Nov 2. J Biol Chem. 2006. PMID: 16269412 Free article.

10

Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.

Ishijima M, Suzuki N, Hozumi K, Matsunobu T, Kosaki K, Kaneko H, Hassell JR, Arikawa-Hirasawa E, Yamada Y. Ishijima M, et al. Matrix Biol. 2012 May;31(4):234-45. doi: 10.1016/j.matbio.2012.02.006. Epub 2012 Mar 7. Matrix Biol. 2012. PMID: 22421594 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters